The Flexible FIGO Classification Concept for Underlying Causes of Abnormal Uterine Bleeding

 

 Buy Article Permissions and Reprints

ABSTRACT

To this juncture, clinical management, teaching of medical providers, and the design and interpretation of clinical trials has been hampered by the absence of a consensus system for the classification of causes or potential causes of abnormal uterine bleeding (AUB). Indeed, more than one possible mechanism may be involved in the development of the bleeding symptoms experienced by a given individual. A consistent and universally accepted classification system could be used by clinicians, investigators, and even patients to facilitate communication, clinical care, and research. The “PALM-COEIN” AUB classification system is the result of several years of collaboration among a spectrum of individuals involved in clinical medicine, teaching, and the basic and clinical sciences and is proposed as a tool that meets the requirements just described but one that is capable of adaptation to our evolving insight into the mechanisms involved in the genesis of AUB. This system has been accepted by the International Federation of Gynecology and Obstetrics (FIGO) as a suitable system for widespread international use.

REFERENCES

• 1 Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding.  Fertil Steril. 2008;  90 2269-2280
  Google Scholar
• 2 Fraser IS, Critchley HO, Munro MG. Abnormal uterine bleeding: getting our terminology straight.  Curr Opin Obstet Gynecol. 2007;  19 591-595
  Google Scholar
• 3 Fraser IS, Critchley HO, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding.  Fertil Steril. 2007;  87 466-476
  Google Scholar
• 4 Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?.  Hum Reprod. 2007;  22 635-643
  Google Scholar
• 5 Benedet JL, Odicino F, Maisonneuve P et al.. Carcinoma of the cervix uteri.  Int J Gynaecol Obstet. 2003;  83 (Suppl 1) 41-78
  Google Scholar
• 6 Revised American Society for Reproductive Medicine classification of endometriosis: 1996.  Fertil Steril. 1997;  67 817-821
  Google Scholar
• 7 Bump RC, Mattiasson A, Bo K et al.. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.  Am J Obstet Gynecol. 1996;  175 10-17
  Google Scholar
• 8 Munro MG. Abnormal Uterine Bleeding. Cambridge: Cambridge University Press; 2010
  Google Scholar
• 9 Munro MG, Critchley H OD, Broder MS, Fraser IS. The FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in non-gravid women of reproductive age.  Int J Gynecol Obstet. 2011;  113 3-13
  Google Scholar
• 10 Critchley H OD, Munro MG, Broder MS, Fraser IS. A five-year international review process concerning terminologies, definitions and related issues around abnormal uterine bleeding.  Semin Reprod Med. 2011;  29 (5) 377-382
  Google Scholar
• 11 Munro MG, Broder MS, Critchley H OD, Matteson K, Hathtootuwa R, Fraser IS. An international response to questions about terminologies, investigation and management of abnormal uterine bleeding: use of an electronic audience respondse system.  Semin Reprod Med. 2011;  29 (5) 436-445
  Google Scholar
• 12 Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study.  J Minim Invasive Gynecol. 2009;  16 465-471
  Google Scholar
• 13 Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN).  Fertil Steril. 2009;  91 201-206
  Google Scholar
• 14 Gordts S, Brosens JJ, Fusi L, Benagiano G, Brosens I. Uterine adenomyosis: a need for uniform terminology and consensus classification.  Reprod Biomed Online. 2008;  17 244-248
  Google Scholar
• 15 Dueholm M. Transvaginal ultrasound for diagnosis of adenomyosis: a review.  Best Pract Res Clin Obstet Gynaecol. 2006;  20 569-582
  Google Scholar
• 16 Togashi K, Nishimura K, Itoh K et al.. Adenomyosis: diagnosis with MR imaging.  Radiology. 1988;  166 111-114
  Google Scholar
• 17 Mark AS, Hricak H, Heinrichs LW et al.. Adenomyosis and leiomyoma: differential diagnosis with MR imaging.  Radiology. 1987;  163 527-529
  Google Scholar
• 18 Dueholm M, Lundorf E, Hansen ES, Sorensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis.  Fertil Steril. 2001;  76 588-594
  Google Scholar
• 19 Lasmar RB, Barrozo PM, Dias R, Oliveira MA. Submucous myomas: A new presurgical classification to evaluate the viability of hysteroscopic surgical treatment-preliminary report.  J Min Invas Gynecol. 2005;  12 308-311
  Google Scholar
• 20 Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension.  Obstet Gynecol. 1993;  82 736-740
  Google Scholar
• 21 Tavassoli FA, Devilee P. World Health Organization Classification of Tumors: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003
  Google Scholar
• 22 Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL et al.. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer.  Int J Gynaecol Obstet. 2006;  95 Suppl 1 S105-143
  Google Scholar
• 23 Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review.  BJOG. 2004;  111 734-740
  Google Scholar
• 24 Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A survey of gynecologists concerning menorrhagia: perceptions of bleeding disorders as a possible cause.  J Womens Health Gend Based Med. 2002;  11 39-44
  Google Scholar
• 25 Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.  Menopause. 2009;  16 50-59
  Google Scholar
• 26 Hale GE, Manconi F, Luscombe G, Fraser IS. Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition.  Obstet Gynecol. 115 249-256
  Google Scholar
• 27 Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding.  Hum Reprod Update. 2002;  8 60-67
  Google Scholar
• 28 Critchley H OD, Maybin JA. Molecular and cellular causes of abnormal uterine bleeding of endometrial origin.  Semin Reprod Med. 2011;  29 (5) 400-409
  Google Scholar
• 29 Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia.  Am J Obstet Gynecol. 1994;  171 178-183
  Google Scholar
• 30 Smith SK, Abel MH, Kelly RW, Baird DT. A role for prostacyclin (PGi2) in excessive menstrual bleeding.  Lancet. 1981;  1 522-524
  Google Scholar
• 31 Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding.  Br J Obstet Gynaecol. 1981;  88 434-442
  Google Scholar
• 32 Pitsos M, Skurnick J, Heller D. Association of pathologic diagnoses with clinical findings in chronic endometritis.  J Reprod Med. 2009;  54 373-377
  Google Scholar
• 33 Heatley MK. The association between clinical and pathological features in histologically identified chronic endometritis.  J Obstet Gynaecol. 2004;  24 801-803
  Google Scholar
• 34 Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding.  Am J Reprod Immunol. 2007;  57 361-366
  Google Scholar
• 35 Endrikat J, Gerlinger C, Plettig K, Wessel J, Schmidt W, Grubb G et al.. A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use.  Gynecol Endocrinol. 2003;  17 107-114
  Google Scholar
• 36 Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding.  Contraception. 2005;  71 402-408
  Google Scholar
• 37 Rosenberg MJ, Waugh MS, Stevens CM. Smoking and cycle control among oral contraceptive users.  Am J Obstet Gynecol. 1996;  174 628-632
  Google Scholar
• 38 Fraser IS, Hickey MH. Endometrial vascular changes and bleeding patterns with long-acting progestogen-only contraceptives.  In: Spitz I (ed), Proceedings of an International Symposium, Jerusalem, August 1999, Progesterone, progestins and the antiprogestins in the next Millenium.  Steroids. 2000;  65 665-670
  Google Scholar
• 39 Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.  Br J Obstet Gynaecol. 1998;  105 592-598
  Google Scholar
• 40 Munro MG, Heikinheimo O, Hathtootuwa R, Tank J, Fraser IS. The need for investigations to elucidate causes and effects of abnormal uterine bleeding.  Semin Reprod Med. 2011;  29 (5) 410-422
  Google Scholar

Malcolm G MunroM.D. 

Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Kaiser Permanente, Southern California

4900 Sunset Boulevard, Station 3-B, Los Angeles, CA 90027

Email: mgmunro@ucla.edu; mgmunro@aol.com